1,708
Participants
Start Date
February 28, 2002
Primary Completion Date
July 31, 2006
Study Completion Date
July 31, 2006
placebo
bupropion hydrochloride
nicotine
MBCCOP-Howard University Cancer Center, Washington D.C.
CCOP - Ann Arbor Regional, Ann Arbor
CCOP - Metro-Minnesota, Saint Louis Park
CCOP - Duluth, Duluth
Mayo Clinic Cancer Center, Rochester
CentraCare Clinic, Saint Cloud
CCOP - Sioux Community Cancer Consortium, Sioux Falls
Rapid City Regional Hospital, Rapid City
CCOP - Merit Care Hospital, Fargo
Altru Health Systems, Grand Forks
Medcenter One Health System, Bismarck
CCOP - Illinois Oncology Research Association, Peoria
CCOP - Carle Cancer Center, Urbana
Cancer Center of Kansas - Wichita, Wichita
CCOP - Missouri Valley Cancer Consortium, Omaha
CCOP - Ochsner, New Orleans
CCOP - Sooner State, Tulsa
CCOP - Scottsdale Oncology Program, Scottsdale
CCOP - Cedar Rapids Oncology Project, Cedar Rapids
CCOP - Iowa Oncology Research Association, Des Moines
Siouxland Hematology-Oncology, Sioux City
CCOP - Wichita, Wichita
CCOP - Toledo Community Hospital Oncology Program, Toledo
CCOP - Geisinger Clinic and Medical Center, Danville
Allan Blair Cancer Centre, Regina
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER